Immediate Impact
52 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Bryan M. Webb being referenced
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bryan M. Webb | 194 | 106 | 26 | 67 | 10 | 316 | |
| Benjamin Buelow | 119 | 160 | 18 | 40 | 9 | 296 | |
| J. L. Montour | 176 | 54 | 14 | 59 | 14 | 289 | |
| Yu Weng | 186 | 83 | 14 | 131 | 14 | 330 | |
| Shouheng Lin | 112 | 152 | 24 | 62 | 10 | 304 | |
| Ginette S. Santiago-Sánchez | 175 | 71 | 9 | 80 | 13 | 300 | |
| Marie‐Therese Haider | 146 | 229 | 13 | 84 | 16 | 323 | |
| Mingchao Ma | 220 | 73 | 15 | 52 | 9 | 348 | |
| Guillaume Gapihan | 160 | 122 | 7 | 115 | 13 | 290 | |
| Jennifer Freytag | 118 | 80 | 26 | 115 | 10 | 312 | |
| Turi Danielsen | 159 | 110 | 6 | 173 | 11 | 363 |
All Works
Login with ORCID to disown or claim papers
Loading papers...